Dr Jens Rengelshausen | Head Translational Science, Global Early Clinical Development
Grünenthal GmbH

Dr. Jens Rengelshausen is a physician with board-certification in clinical pharmacology. He is holding a Senior Director position as Head of Translational Science at Grünenthal GmbH in Aachen, Germany. His current work comprises the identification and validation of biomarkers and experimental disease models for drug development. Before, he was a resident in Internal Medicine at the University Hospital Essen and in Clinical Pharmacology at the University Hospital Heidelberg where he conducted clinical research on transporter-based drug-drug interactions and pharmacogenetics. He spent a scholarship year at the St. Jude Children’s Research Hospital in Memphis, Tennessee focusing on pharmacogenomics research. Since 2010, he is also a board member of the Association for Applied Human Pharmacology (AGAH).